Recombinant Human KIF7 Protein, N-His

Description of Recombinant Human KIF7 Protein, N-His

Introduction

Recombinant proteins are proteins that are produced through genetic engineering techniques, allowing for the production of large quantities of a specific protein for research and therapeutic purposes. One such protein is Recombinant Human KIF7 Protein, which has gained significant attention in the scientific community due to its unique structure and diverse range of activities. In this article, we will explore the structure, activity, and application of Recombinant Human KIF7 Protein.

Structure of Recombinant Human KIF7 Protein

Recombinant Human KIF7 Protein is a member of the kinesin superfamily, a group of motor proteins that play crucial roles in intracellular transport and cell division. It is encoded by the KIF7 gene located on chromosome 15 in humans. The protein consists of 1,703 amino acids and has a molecular weight of approximately 190 kDa.

The structure of Recombinant Human KIF7 Protein is characterized by a globular N-terminal motor domain, a central coiled-coil domain, and a C-terminal tail domain. The motor domain contains the ATPase activity responsible for the movement of the protein along microtubules, while the coiled-coil domain is involved in protein-protein interactions. The C-terminal tail domain is highly variable and is responsible for the diverse range of activities exhibited by Recombinant Human KIF7 Protein.

Activity of Recombinant Human KIF7 Protein

Recombinant Human KIF7 Protein has been shown to have multiple activities, making it a versatile protein with various functions in different cellular processes. Its main activity is as a microtubule-based motor protein, responsible for the transport of cellular cargo along microtubules. This activity is crucial for intracellular transport, cell division, and cell migration.

In addition to its motor activity, Recombinant Human KIF7 Protein has also been shown to have regulatory functions in the Hedgehog signaling pathway. It acts as a negative regulator of this pathway by binding to and inhibiting the activity of the Hedgehog signaling protein, Smoothened. This activity is essential for proper embryonic development and tissue homeostasis.

Furthermore, Recombinant Human KIF7 Protein has been found to interact with various other proteins, including the tumor suppressor protein, APC, and the cell adhesion protein, β-catenin. These interactions suggest that Recombinant Human KIF7 Protein may play a role in cell adhesion and cell signaling pathways.

Applications of Recombinant Human KIF7 Protein

Due to its diverse range of activities, Recombinant Human KIF7 Protein has various potential applications in both research and therapeutic settings. Its role as a motor protein makes it a valuable tool for studying intracellular transport and cell division processes. It has also been used in studies investigating the Hedgehog signaling pathway and its implications in developmental disorders and cancer.

In therapeutic applications, Recombinant Human KIF7 Protein has shown promise in treating diseases related to abnormal Hedgehog signaling, such as basal cell carcinoma and medulloblastoma. Its ability to inhibit the activity of Smoothened makes it a potential target for drug development in these diseases.

Additionally, Recombinant Human KIF7 Protein has been explored as a potential target for gene therapy in diseases caused by mutations in the KIF7 gene. This approach involves replacing the defective gene with a functional copy of the gene, allowing for the production of Recombinant Human KIF7 Protein with normal activity.

Conclusion

In summary, Recombinant Human KIF7 Protein is a unique and versatile protein with a complex structure and diverse range of activities. Its role as a motor protein, regulatory protein, and interaction partner makes it a valuable tool